Tags: acute pulmonary embolismpulmonary embolismanticoagulantbleedingprotamine
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - about 1 year ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - about 1 year ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - over 1 year ago Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL - over 1 year ago | |
| 2 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Mezigdomide Combinations Show Promise in Multiple Myeloma - 3 months ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 9 months ago | |
| 3 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | ||
| 4 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 5 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 6 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 7 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves Earlier Use of CAR-T Products for Myeloma - 12 months ago FDA Approves New Frontline Regimen for Aggressive ALL - about 1 year ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - about 1 year ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - over 1 year ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - over 1 year ago Completely Oral Regimen Effective, Feasible in APL - over 1 year ago | |
| 8 | Judy George MedPage Today Medical reporter, writer. | ||
| 9 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 10 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey |